Stock Track | Moderna Soars 6.31% in Night Session on Strong Vaccine Data and Revenue Beat

Stock Track

6 hours ago

Moderna, Inc. (MRNA) experienced a significant surge of 6.31% during the night session, driven by multiple positive catalysts that boosted investor sentiment.

The movement was fueled by encouraging Phase 1 clinical data for Moderna's mRNA-based hantavirus vaccine, which showed favorable tolerability and elicited robust antibody responses. Additionally, the company reported first-quarter revenue of $389 million, substantially exceeding the analyst consensus estimate of $228 million. Further support came from positive first-in-human data for its personalized mRNA cancer therapeutic vaccine EVM16 and an upward revision of the stock's target price by UBS.

These developments highlight the continued potential of Moderna's mRNA platform across various therapeutic areas, contributing to the strong upward price movement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1181983787"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1181983787\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1181983787?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-11 08:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181983787","market":"sg","top_or_hot":-1,"title":"Stock Track | Moderna Soars 6.31% in Night Session on Strong Vaccine Data and Revenue Beat","media":"Stock Track","content":"<p>Moderna, Inc. (MRNA) experienced a significant surge of 6.31% during the night session, driven by multiple positive catalysts that boosted investor sentiment.</p><p>The movement was fueled by encouraging Phase 1 clinical data for Moderna's mRNA-based hantavirus vaccine, which showed favorable tolerability and elicited robust antibody responses. Additionally, the company reported first-quarter revenue of $389 million, substantially exceeding the analyst consensus estimate of $228 million. Further support came from positive first-in-human data for its personalized mRNA cancer therapeutic vaccine EVM16 and an upward revision of the stock's target price by UBS.</p><p>These developments highlight the continued potential of Moderna's mRNA platform across various therapeutic areas, contributing to the strong upward price movement.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Soars 6.31% in Night Session on Strong Vaccine Data and Revenue Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Soars 6.31% in Night Session on Strong Vaccine Data and Revenue Beat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-11 08:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna, Inc. (MRNA) experienced a significant surge of 6.31% during the night session, driven by multiple positive catalysts that boosted investor sentiment.</p><p>The movement was fueled by encouraging Phase 1 clinical data for Moderna's mRNA-based hantavirus vaccine, which showed favorable tolerability and elicited robust antibody responses. Additionally, the company reported first-quarter revenue of $389 million, substantially exceeding the analyst consensus estimate of $228 million. Further support came from positive first-in-human data for its personalized mRNA cancer therapeutic vaccine EVM16 and an upward revision of the stock's target price by UBS.</p><p>These developments highlight the continued potential of Moderna's mRNA platform across various therapeutic areas, contributing to the strong upward price movement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1181983787","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181983787","pubTimestamp":1778457828,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Moderna, Inc. (MRNA) experienced a significant surge of 6.31% during the night session, driven by multiple positive catalysts that boosted investor sentiment.The movement was fueled by encouraging...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"个股赛道|Moderna夜盘大涨6.31%疫苗数据强劲营收超预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Moderna, Inc. (MRNA) experienced a significant surge of 6.31% during the night session, driven by multiple positive catalysts that boosted investor sentiment.The movement was fueled by encouraging Phase 1 clinical data for Moderna's mRNA-based hantavirus vaccine, which showed favorable tolerability and elicited robust antibody responses. Additionally, the company reported first-quarter revenue of $389 million, substantially exceeding the analyst consensus estimate of $228 million. Further support came from positive first-in-human data for its personalized mRNA cancer therapeutic vaccine EVM16 and an upward revision of the stock's target price by UBS.These developments highlight the continued potential of Moderna's mRNA platform across various therapeutic areas, contributing to the strong upward price movement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}